How Cell and Gene Manufacturers Can Scale to Meet Demand

December 21, 2022
Cara Schildmeyer

Between 2022 and 2030, the cell and gene therapy sector is expected to experience a compound annual growth rate (CAGR) of 39.42 percent, BioSpace said of a recent Vision Research Report.

This is quite a large anticipated growth; how will startups and current manufacturing companies work to meet this growing demand?

On today’s episode of Exceeding Your Benchmark, Host Sumit Verma, Senior Vice President, Global Strategic Manufacturing at Iovance Biotherapeutics, addresses cell and gene therapy industry trends and challenges and what manufacturers can do to promote growth in the sector.

Verma also discussed…

  1. The greatest challenges biopharma startups face
  2. How established CGT manufacturers are preparing to meet an increased demand
  3. What place automation has in advanced cell manufacturing

Verma believes there are three key areas manufacturers need to target to help supply meet increasing demand. “I think most players are focusing on three big things: one is around scalability, the second is around supply chain, making sure we have all the components, and last is about talent. Verma said of the talent piece, “There aren’t many people who have advanced programs for therapeutic manufacturing today…there are a lot of synergies and the big pharma have done a great job establishing developing programs that are very supportive of their large plants and their scalable efforts and we’ve seen the need to do that in cell and gene therapy.

Recent Episodes

nurses have shaped modern society
View episode

  Nurses Have Shaped Modern Society beyond healthcare to stand as pivotal figures that transcend their traditional roles, influencing the broader spectrum of societal change. Healthcare Rethink, a FinThrive podcast hosted by Brian Urban, welcomes Sarah DiGregorio, Journalist, Author, and Speake,r to discuss her second book, “Taking Care: The Story of Nursing and Its Power […]

View episode

  Healthcare is often synonymous with invasive procedures and impersonal treatment, but virtual care and its varying models are increasingly changing that. For this reason, this constantly changing landscape needs transformative leaders like Dr. Ryan Grant, Co-founder and CEO of Vori Health. His own transition from a surgical focus to tackling broader challenges in the […]

remake medicine
View episode

  Can art help remake medicine with the therapeutic potential to make a difference in healthcare? The rise of holistic approaches to well-being provides an opportunity to bring out the artistic side in healthcare. And on the latest episode of the Healthcare Rethink Podcast, host Brian Urban takes a deeper look into that intersection between […]